The Y181C substitution in 3'-azido-3'-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer (Q38351813)

From Wikidata

Jump to navigation Jump to search

scientific article

The Y181C Substitution in 3′-Azido-3′-deoxythymidine-resistant Human Immunodeficiency Virus, Type 1, Reverse Transcriptase Suppresses the ATP-mediated Repair of the 3′-Azido-3′-deoxythymidine 5′-Monophosphate-terminated Primer

Language	Label	Description	Also known as
English	The Y181C substitution in 3'-azido-3'-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer	scientific article	The Y181C Substitution in 3′-Azido-3′-deoxythymidine-resistant Human Immunodeficiency Virus, Type 1, Reverse Transcriptase Suppresses the ATP-mediated Repair of the 3′-Azido-3′-deoxythymidine 5′-Monophosphate-terminated Primer

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

The Y181C substitution in 3'-azido-3'-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer (English)

1 reference

Europe PubMed Central

2 September 2017

1 reference

based on heuristic

inferred from title

7

object named as

Bruno Canard

1 reference

Europe PubMed Central

2 September 2017

author name string

Boulbaba Selmi

1

1 reference

Europe PubMed Central

2 September 2017

Jerome Deval

2

1 reference

Europe PubMed Central

2 September 2017

Karine Alvarez

3

1 reference

Europe PubMed Central

2 September 2017

Joelle Boretto

4

1 reference

Europe PubMed Central

2 September 2017

Simon Sarfati

5

1 reference

Europe PubMed Central

2 September 2017

Catherine Guerreiro

6

1 reference

Europe PubMed Central

2 September 2017

language of work or name

0 references

publication date

5 August 2003

1 reference

Europe PubMed Central

2 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

2 September 2017

278

1 reference

Europe PubMed Central

2 September 2017

42

1 reference

Europe PubMed Central

2 September 2017

40464-40472

1 reference

Europe PubMed Central

2 September 2017

Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

The M184V mutation reduces the selective excision of zidovudine 5'-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidine

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Structural basis for activation of α-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

An integrated system to study multiply substituted human immunodeficiency virus type 1 reverse transcriptase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Refined model for primer/template binding by HIV-1 reverse transcriptase: pre-steady-state kinetic analyses of primer/template binding and nucleotide incorporation events distinguish between different binding modes depending on the nature of the nuc

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Inhibition of the initiation of HIV-1 reverse transcription by 3'-azido-3'-deoxythymidine. Comparison with elongation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

The valine-to-threonine 75 substitution in human immunodeficiency virus type 1 reverse transcriptase and its relation with stavudine resistance.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Multidrug-resistant HIV-1 reverse transcriptase: involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Human immunodeficiency virus reverse transcriptase ribonuclease H: specificity of tRNALys3-primer excision

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Characterisation of foscarnet-resistant strains of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Mechanism by which phosphonoformic acid resistance mutations restore 3'-azido-3'-deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

The emergence of different resistance mechanisms toward nucleoside inhibitors is explained by the properties of the wild type HIV-1 reverse transcriptase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an alpha-boranophosphate nucleoside analogue.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

A detailed model of reverse transcription and tests of crucial aspects

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Epitope mapping of the monoclonal antibody FAC2 on the apoprotein of Cpa-1 in photosystem II

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302928200

21 January 2018

Identifiers

10.1074/JBC.M302928200

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38351813&oldid=1755615240"